Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 10:00 (CET) to 20 November 2025, 12:00 (CET)

Agenda of the HMPC meeting 17-19 November 2025

Medicinal products for human use: monthly figures - October 2025

Human medicines European public assessment report (EPAR): Isentress, raltegravir, Date of authorisation: 19/12/2007, Revision: 45, Status: Authorised

Improved scientific advice for medicines for public health threats including antimicrobial resistance

Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Date of authorisation: 08/09/2015, Revision: 11, Status: Authorised

Scientific advice for public health emergencies and threats

Guidance for applicants: the ETF scientific advice that facilitates clinical trial authorisations (SA-CTA)

Human medicines European public assessment report (EPAR): Corlentor, ivabradine, Date of authorisation: 25/10/2005, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Procoralan, ivabradine, Date of authorisation: 25/10/2005, Revision: 24, Status: Authorised